Author

C. Li-Ma

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

M. J. Bollong· 3 shared C. Stanton· 2 shared K. Nutsch· 2 shared L. Wiseman· 2 shared T. Nguyen· 2 shared E. Chen· 1 shared E. M. Grzelak· 1 shared E. Saez· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

M. J. Bollong

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Covalent targeting as a common mechanism for inhibiting NLRP3 inflammasome assembly.

C. Stanton, J. Sun, K. Nutsch, J. D. Rosarda, T. Nguyen, C. Li-Ma, S. Kutseikin, E. Saez, J. R. Teijaro, L. Wiseman, M. J. Bollong

This study identifies covalent compounds that inhibit NLRP3 inflammasome assembly by targeting reactive cysteines, suggesting NLRP3 as an electrophile sensor for inflammatory signaling.

bioRxiv · Jun 1, 2023Biochemistry

Succinylation of a KEAP1 sensor lysine promotes NRF2 activation

L. Ibrahim, C. Stanton, K. Nutsch, T. Nguyen, C. Li-Ma, Y. Ko, G. C. Lander, L. Wiseman, M. J. Bollong

The paper identifies succinylation of KEAP1 lysine 131 as a mechanism to activate NRF2 transcriptional signaling through metabolic regulation.

bioRxiv · May 8, 2023Cell Biology

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2

M. L. Bulos, E. M. Grzelak, C. Li-Ma, E. Chen, M. Hull, K. A. Johnson, M. J. Bollong

The paper identifies SM04690, a CLK2 inhibitor, as a YAP activator by promoting alternative splicing of AMOTL2, leading to reduced YAP phosphorylation and membrane localization.

bioRxiv · Apr 19, 2023 · PreprintCell Biology